Advances in the development of antileishmanial treatments
May 28, 2019Our team in Madrid was involved in the development of antileishmanial compounds. This research was made in collaboration with GSK and Dundee University.
Read More
Results of the Nanofacturing project
April 16, 2019GalChimia thanks all the partners of the Nanofacturing project for the involvement and teamwork that have been key to obtaining the results.
Read More
Droughtdrugs Project, discovery of agrochemicals to improve drought tolerance in crop plants
February 26, 2019The main objective of the Droughtdrugs Project is to develop a new generation of compounds that can activate drought tolerance in crop plants.
Read More
GalChimia, Oncostellae y AMSlab presentan el proyecto IO4COLON
February 25, 2019IO4COLON es una iniciativa de investigación liderada por GalChimia, Oncostellae y AMSlab para el descubrimiento de nuevos fármacos contra el cáncer de colon
Read More
GalChimia is happy to be part of a collaborative effort to boost EU Synthetic Biology competitiveness
January 17, 2019An 8 million Euros grant was attributed by the EU to the ShikiFactory100 project, an international effort coordinated by biotech SME SilicoLife, in cooperation with some of the most relevant players in Europe, covering leading research institutions, SMEs and a large industrial company.
Read More
Resultados del proyecto Mytitox
July 2, 2018During the project, the synthesis of a COF (Covalent Organic Framework), capable of being used to capture toxins in the marine environment to predict toxic episodes, has been scaled.
Read More
Resultados del proyecto NEOGALFARM
July 2, 2018Ya están publicados los resultados del Proyecto NEOGALFARM, centrado en la búsqueda de nuevos fármacos para el tratamiento contra el cáncer mediante el desarrollo de terapias dirigidas a diferentes dianas terapéuticas y de tratamientos combinados. ¡Consúltalos aquí!
Read More
Update on Mytitox project
May 11, 2018New updates on Mytitox Project. All the information here!
Read More
How is GalChimia’s R&D going?
February 8, 2018Galchimia’s R&D activities in 2018 will focus on four projects: Nanofacturing, Biogreen, Neogalfarm and Mytitox.
Read More